Postbiotics Market Impressive Growth at 9.2%

Aboli More
Aboli More

Updated · Jan 19, 2026

SHARE:

Market.us News, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Learn more.
close
Advertiser Disclosure

At Market.us News, We strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us News. We appreciate your support and look forward to continuing to provide valuable insights for our audience.

Overview

New York, NY – Jan 19, 2026 – The global postbiotics market is projected to grow steadily, reaching a value of around USD 305.3 million by 2034, up from USD 126.6 million in 2024, expanding at a CAGR of 9.2% between 2025 and 2034. This growth reflects increasing scientific interest in gut-health ingredients that deliver consistent functional benefits without relying on live microorganisms.

Probiotics are live microorganisms commonly found in foods such as yogurt, sauerkraut, and certain cheeses, where they help maintain digestive health by supporting a balanced gut microbiome that contains nearly 100 trillion microorganisms. Prebiotics, on the other hand, act as food for these beneficial microbes and are present in fiber-rich foods like beans, whole grains, and specific vegetables. However, probiotic products face stability challenges. For example, a supplement formulated to deliver 60 billion CFU at the end of its shelf life may lose up to 75% of its viability during storage. To address this, manufacturers may overfill products to 240 billion CFU, resulting in a final product that includes a large proportion of non-viable microbial cells, whose long-term effects remain largely unexplored.

Postbiotics represent a different and emerging approach. They consist of non-viable microbial components and fermentation-derived compounds such as metabolites, proteins, lipids, carbohydrates, vitamins, organic acids, and cell wall fragments. Unlike probiotics, postbiotics do not depend on microbial survival but instead exert their benefits through bioactive substances present in the fermented matrix. These compounds can influence immune responses by stimulating anti-inflammatory cytokines like IL-10 and IL-4 while suppressing pro-inflammatory markers such as IL-6 and IL-8.

In disease-related applications, particularly cancer, postbiotics have shown potential to induce apoptosis and limit tumor cell proliferation. Yeast-derived cell wall components can interact with epithelial pattern recognition receptors, triggering immune responses such as the release of SBD-1. However, the functional properties of postbiotics are highly sensitive to production and processing methods. Techniques like heat treatment, irradiation, sonication, or high-pressure processing can alter their composition by denaturing proteins or damaging nucleic acids. As a result, the biological response to postbiotics varies depending on the microbial source and the specific processing conditions used, making standardization and formulation key factors in their commercial development.

Key Takeaways

  • The Global Postbiotics Market is expected to grow from USD 126.6 million in 2024 to USD 305.3 million by 2034 at a 9.2% CAGR.
  • Bacteria dominated the By Source segment in 2024 with a 62.8% share due to immunomodulatory and digestive benefits.
  • Dry form led the By Form segment in 2024 with a 69.9% share for its storage, transport, and heat stability advantages.
  • Dietary Supplements held a 43.2% share in the By Application segment in 2024, driven by demand for digestive and immunity products.
  • North America captured 42.8% of the market in 2024, valued at USD 54.3 million, fueled by consumer focus on gut health and wellness.

➤ For a deeper understanding, click on the sample report link: https://market.us/report/postbiotics-market/free-sample/

Report Scope

Market Value (2024)USD 126.6 Million
Forecast Revenue (2034)USD 305.3 Million
CAGR (2025-2034)9.0%
Segments CoveredBy Source (Bacteria, Yeast), By Form (Dry, Liquid), By Application (Functional Food and Beverages, Dietary Supplements, Cosmetics and Personal Care Products, Animal Feed, Pharmaceutical, Others)
Competitive LandscapeArcher Daniels Midland Company, BASF SE, Beekeeper’s Naturals, Inc., Bioflag Group, Cargill, Incorporated, DSM-Firmenich AG, Essential Formulas Incorporated, Glac Biotech Co., Ltd., Ildong Pharmaceutical Co., Ltd., Kerry Group plc.

➤ Directly purchase a copy of the report – https://market.us/purchase-report/?report_id=162014

Key Market Segments

By Source:
In 2024, bacteria emerged as the leading source in the Postbiotics Market, accounting for a 62.8% market share. This dominance is driven by their well-documented efficacy, consistent stability, and strong immunomodulatory effects. Bacterial postbiotics are widely used to support digestive health, strengthen gut barrier function, and reduce inflammation, making them highly suitable for dietary supplements and functional food products. Their reliability and broad scientific backing continue to reinforce their preference among manufacturers.

Take advantage of our unbeatable offer - buy now!

Yeast-based postbiotics, while holding a smaller share, are gradually gaining momentum. Ongoing research highlights their nutrient-rich profile and benefits for skin health, particularly their antioxidant and moisture-retention properties. These features make yeast postbiotics attractive for cosmetics, skincare formulations, and certain beverage applications. Steady growth is expected as their use expands in niche wellness and food-related applications.

By Form:
In 2024, the dry form dominated the Postbiotics Market by form, capturing a 69.9% share. Dry postbiotics are favored due to their superior stability, extended shelf life, and ease of handling. They are especially compatible with powdered supplements and processed food products, where heat stability and formulation flexibility are critical. Their convenience in storage and transportation further strengthens their widespread adoption.

Liquid postbiotics are seeing increasing interest, particularly in functional beverages and cosmetic formulations. This form enables quicker absorption and easier blending with other bioactive ingredients. Although adoption remains lower than dry formats, liquid postbiotics are gaining attention in personalized nutrition and skincare solutions, where rapid bioavailability and formulation versatility are key advantages.

By Application:
Dietary supplements led the Postbiotics Market by application in 2024, holding a 43.2% share. Rising awareness of gut health, immunity, and preventive wellness has fueled strong demand for supplement-based postbiotic products. Their availability in capsules and powders has helped maintain consumer confidence and ensured consistent market penetration across health-focused demographics.

Functional food and beverage applications are expanding as manufacturers incorporate postbiotics into products such as yogurts, fermented drinks, and nutrition bars. These ingredients provide probiotic-like benefits without relying on live cultures, while also supporting flavor and product stability. Growing demand for ready-to-drink and fortified foods is expected to further boost adoption in this segment.

Cosmetics and personal care products are increasingly using postbiotics for their calming, anti-inflammatory, and microbiome-supporting properties. Their inclusion in creams, serums, and haircare products helps improve skin barrier function and reduce sensitivity. Rising consumer preference for microbiome-friendly and science-backed skincare solutions continues to drive growth in this application area.

List of Segments

By Source

  • Bacteria
  • Yeast

By Form

  • Dry
  • Liquid

By Application

  • Functional Food and Beverages
  • Dietary Supplements
  • Cosmetics and Personal Care Products
  • Animal Feed
  • Pharmaceutical
  • Others

Regional Analysis

In 2024, North America emerged as the leading region in the global postbiotics market, accounting for a 42.8% share with an estimated market value of USD 54.3 million. This strong position is largely driven by a rapid shift in consumer preference toward digestive health and immunity-focused nutritional solutions. Growing awareness of postbiotics as stable, science-backed alternatives to live probiotics has supported their widespread use in dietary supplements and functional food products across the region.

Rising incidences of gastrointestinal disorders, along with an expanding aging population seeking safe and effective gut-health solutions, have further strengthened market demand. Postbiotics are increasingly favored for their safety, consistency, and longer shelf life compared to probiotics. The United States represents the largest contributor within North America, supported by robust clinical research and funding initiatives from institutions such as the National Institutes of Health, alongside sustained investments by nutraceutical and functional food manufacturers focused on microbiome-driven health innovations.

Top Use Cases

Shelf-stable gut-health supplements: Postbiotics are used when brands want “probiotic-like” benefits without relying on live cells that can die off during storage and shipping. This is especially useful for mass retail supplements where stability matters. Demand for microbiome products is already visible in consumer behavior: a U.S. national survey reported about 1.6% of adults (~4 million people) used probiotics/prebiotics in the prior 30 days.

Functional foods where live cultures are hard to maintain: In food manufacturing, heat, pressure, and long distribution cycles can reduce viability of live cultures—so postbiotics (inanimate microbes/lysates/metabolites) are increasingly positioned for processed foods and shelf-stable functional products. A related regulatory signal in fermented dairy: the U.S. FDA’s yogurt standard allows an optional “live and active cultures” claim only when yogurt meets minimum culture counts—≥10⁷ CFU/g at manufacture and a reasonable expectation of ≥10⁶ CFU/g through shelf life. For yogurt treated to inactivate microbes after culturing, labeling must state it “does not contain live and active cultures.” This pushes some innovation toward non-living bioactives, including postbiotic-style ingredients, for consistent performance.

Pediatric immune support and fewer common infections: A strong use case is heat-inactivated (non-living) microbial preparations for children, where safety and consistency are priorities. A systematic review of RCTs reported that heat-inactivated Lactobacillus paracasei CBA L74 (vs placebo) in two RCTs (n = 537) reduced risk of diarrhea (RR 0.51) and also lowered pharyngitis (RR 0.31) and laryngitis (RR 0.44). These outcomes make postbiotic approaches attractive for pediatric nutrition products positioned around “everyday immune support.”

Immune support for older adults : Postbiotics are also explored for immune resilience in aging populations. In one double-blind, placebo-controlled trial, 28 healthy adults aged 50–70 took heat-killed Lactobacillus gasseri TMC0356 at 1.0×10⁹ CFU/day for 4 weeks, assessing immune-related responses via blood samples (PBMCs). While product claims depend on full study outcomes and regulatory rules, this type of clinical design supports the use of postbiotics in senior-focused nutrition and wellness formulations.

Microbiome-friendly skincare and sensitive-skin barrier support: Postbiotics are increasingly used in cosmetics as ferment lysates or inanimate microbial components to support barrier function and calm visible irritation. Sensitive skin is common—one paper cites prevalence of ~60–70% in females and ~50–60% in males in industrialized countries. In a clinical study of a lotion containing fermented lysates, users applied the product for 30 days, and the study reported significant improvements in barrier-related measures such as reduced transepidermal water loss (TEWL) and increased moisturization. Separately, a review identified 14 published clinical trials using cosmetic products with specific probiotic/postbiotic strains or components, reflecting rising clinical activity in this use case.

Conclusion

In conclusion, postbiotics represent a distinct and promising class of microbiome-related compounds that are increasingly valued in health, nutrition, and wellness markets for their stability, safety, and reproducible benefits. Unlike probiotics, which rely on live microorganisms, postbiotics consist of inactivated microbial cells and metabolic byproducts that still deliver positive effects on gut barrier strength, immune modulation, and inflammation control. Researchers have documented benefits such as enhanced gut function, reduced symptoms of digestive disorders, and strengthened immune responses, often with fewer safety concerns than live cultures—especially for people with sensitive or compromised immune systems.

Discuss Your Needs With Our Analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

market.us support
SHARE:
Request a Sample Report
We'll get back to you as quickly as possible